Skip to content

Effect of Yoga on Gut, Heart, and Brain function in patients with Heart Failure

Exploring the Gut Microbiome Diversity and Influence of Yoga based Cardiac Rehabilitation on Gut-Heart-Brain Axis (YoGH-Biome) in Heart Failure - YoGH-Biome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060757
Enrollment
60
Registered
2023-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I502- Systolic (congestive) heart failure

Interventions

Intervention1: Yoga-CaRe programme: Yoga-CaRe programme participants will receive 20 supervised sessions spread over a period of three months scheduled twice a week for the first seven weeks and once

Sponsors

Indian Council of Medical Research (ICMR)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from HF and healthy individuals will be selected for the study. The inclusion criteria for study eligibility for HF patients will be as follows: Male and female patients above 18 years; Physician diagnosed HF based on ESC guidelines, and patients should be NYHA class II/III; HF with reduced ejection fraction = 40%.

Exclusion criteria

Exclusion criteria: Comorbid disease or behavioral or other limitations that interfere with performing Yoga training or prevent the completion of 1 y of exercise training; Elective Cardiovascular procedure or hospitalization planned in the coming 3 months; Heart failure secondary to significant correctable/reversible cause like primary valvular disease/ correctable congenital heat disease; participation in exercise training/yoga at regular intervals (more than once per week) at a moderate-to-vigorous intensity at any time in the last 6 weeks; and participation in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Alteration in the composition of gut microbiomeTimepoint: 3 months

Secondary

MeasureTime frame
Changes in the gut-microbiota derived metabolites and inflammatory biomarkersTimepoint: 3 months

Countries

India

Contacts

Public ContactDr Satish G Patil

SDM College of Medical Sciences and Hospital

satish.patil@sdmuniversity.edu.in9986789583

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026